Chronic Heart Failure Chronic Obstructive Pulmonary Disease
Conditions
Interventions
Sponsors
Ciro+
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Patients with COPD as a primary diagnosis according to the Global Initiative For Chronic Obstructive Pulmonary Lung Disease (GOLD) definition: *Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible.The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases*. COPD is diagnosed by a chest physician. Patients with mild (GOLDI; FEV1/FVC=80% of predicted value) to very severe (GOLDIV; FEV1/FVC
Exclusion criteria
Exclusion criteria: -Neuromuscular co-morbidities. Patients with neuromuscular co-morbidities can experience problems, not caused by COPD or CHF, during the performance of the activities of daily life. -Lack of motivation for voluntary participation in this study. -Patients with long-term oxygen therapy use will be excluded for measurements of metabolic load.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference in ventilation and oxygen uptake during the performance of ADL before and after rehabilitation. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Difference in physical activity -Difference in heart rate -Difference in time to accomplish the ADLs -Difference in Borg symptom scores after the performance of ADLs -Differences in COPM (patients scores on performance and satisfaction) | — |
Countries
Netherlands
Outcome results
None listed